← Back to Search

Procedure

Ablation for Atrial Flutter

N/A
Recruiting
Led By Aneesh Tolat, MD
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at one month after ablation
Awards & highlights

Study Summary

This trial will evaluate the safety, feasibility, and efficacy of performing atrial flutter ablation through the arm vs. the standard femoral vein approach. #MedicalStudy #AtrialFlutter

Who is the study for?
This trial is for outpatients weighing at least 50 kg with documented typical atrial flutter, referred for right atrial flutter ablation. It's not open to inpatients, those unable to consent, individuals under 50 kg, or patients with a pacemaker or defibrillator with transvenous leads.Check my eligibility
What is being tested?
The study tests the safety and effectiveness of performing atrial flutter ablation through the arm instead of the femoral vein. It compares recovery time, success rates of maintaining sinus rhythm without recurrence, complication rates including bleeding and heart issues, and pain severity at insertion sites between both methods.See study design
What are the potential side effects?
Potential side effects include complications from accessing veins such as bleeding or thrombosis (clotting), heart perforation during the procedure, discomfort at the site where catheters are inserted into the body (either arm or groin), and possible failure to maintain normal heart rhythm post-procedure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at one month after ablation
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at one month after ablation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Recovery time
Secondary outcome measures
Complication rate
Frequency of complications
One month success rate
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Ablation through upper extremityExperimental Treatment1 Intervention
Ablation through arm
Group II: Ablation through femoral veinActive Control1 Intervention
Ablation through vein

Find a Location

Who is running the clinical trial?

Hartford HospitalLead Sponsor
133 Previous Clinical Trials
18,892 Total Patients Enrolled
Aneesh Tolat, MDPrincipal InvestigatorHartford Hospital
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Ablation through femoral vein (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05755074 — N/A
Atrial Flutter Research Study Groups: Ablation through upper extremity, Ablation through femoral vein
Atrial Flutter Clinical Trial 2023: Ablation through femoral vein Highlights & Side Effects. Trial Name: NCT05755074 — N/A
Ablation through femoral vein (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05755074 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently participating in this clinical experiment?

"Affirmative, the information on clinicaltrials.gov affirms that this trial is still recruiting participants. The study was first posted on October 28th 2021 and has most recently been updated in March 2nd 2023. Presently, 40 volunteers must be sourced from 1 medical centre."

Answered by AI

Are participants currently being enrolled in this experiment?

"Correct. Clinicaltrials.gov reveals that this clinical trial is still enlisting participants; initial posting was on October 28th 2021 and the information has been updated as recently as March 2nd 2023. The study requires 40 patients from a single site to complete its enrolment goals."

Answered by AI
~11 spots leftby Apr 2025